Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
Descriptor ID |
D004359
|
MeSH Number(s) |
E02.319.310
|
Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 5 | 7 |
1995 | 1 | 5 | 6 |
1996 | 2 | 9 | 11 |
1997 | 1 | 2 | 3 |
1998 | 1 | 5 | 6 |
1999 | 1 | 7 | 8 |
2000 | 2 | 7 | 9 |
2001 | 0 | 3 | 3 |
2002 | 2 | 10 | 12 |
2003 | 0 | 25 | 25 |
2004 | 1 | 23 | 24 |
2005 | 0 | 15 | 15 |
2006 | 0 | 17 | 17 |
2007 | 0 | 18 | 18 |
2008 | 0 | 30 | 30 |
2009 | 0 | 23 | 23 |
2010 | 0 | 24 | 24 |
2011 | 1 | 25 | 26 |
2012 | 1 | 18 | 19 |
2013 | 1 | 16 | 17 |
2014 | 0 | 20 | 20 |
2015 | 0 | 29 | 29 |
2016 | 3 | 22 | 25 |
2017 | 3 | 12 | 15 |
2018 | 1 | 18 | 19 |
2019 | 1 | 20 | 21 |
2020 | 0 | 11 | 11 |
2021 | 0 | 13 | 13 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349). Clin Infect Dis. 2023 02 08; 76(3):e580-e589.
-
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial. Am J Respir Crit Care Med. 2022 05 15; 205(10):1228-1235.
-
Latent Tuberculosis Infection. N Engl J Med. 2021 12 09; 385(24):2271-2280.
-
Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program. Epilepsia. 2022 01; 63(1):139-149.
-
Inhibition of Polyamine Biosynthesis Using Difluoromethylornithine Acts as a Potent Immune Modulator and Displays Therapeutic Synergy With PD-1-blockade. J Immunother. 2021 10 01; 44(8):283-291.
-
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE. Pediatr Rheumatol Online J. 2021 Aug 30; 19(1):137.
-
Efficacy of Home Anticonvulsant Administration for Second-Line Status Epilepticus Treatment. Neurology. 2021 08 17; 97(7):e720-e727.
-
Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid Stenosis. J Stroke Cerebrovasc Dis. 2021 Aug; 30(8):105918.
-
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. N Engl J Med. 2021 07 01; 385(1):23-34.
-
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718.